Proteus mirabilis and Urinary Tract Infections
JN Schaffer, MM Pearson - Urinary tract infections: Molecular …, 2017 - Wiley Online Library
Proteus mirabilis is well known in clinical laboratories and microbiology survey courses as
the species that swarms across agar surfaces, overtaking any other species present in the …
the species that swarms across agar surfaces, overtaking any other species present in the …
An update on the management of urinary tract infections in the era of antimicrobial resistance
MS Bader, M Loeb, AA Brooks - Postgraduate medicine, 2017 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …
Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies
O Fasugba, A Gardner, BG Mitchell… - BMC infectious …, 2015 - Springer
Background During the last decade the resistance rate of urinary Escherichia coli (E. coli) to
fluoroquinolones such as ciprofloxacin has increased. Systematic reviews of studies …
fluoroquinolones such as ciprofloxacin has increased. Systematic reviews of studies …
Pattern of antibacterial resistance in urinary tract infections: A systematic review and meta-analysis
SAR Mortazavi-Tabatabaei… - International journal …, 2019 - pmc.ncbi.nlm.nih.gov
Background: Urinary tract infection (UTI) is one of the most common infectious diseases
ranking next to upper respiratory tract infections. UTIs are often significantly associated with …
ranking next to upper respiratory tract infections. UTIs are often significantly associated with …
Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014
SH Lob, LE Nicolle, DJ Hoban, KM Kazmierczak… - … and infectious disease, 2016 - Elsevier
Increasing antimicrobial resistance in urinary tract infections (UTI) is a concern. To evaluate
resistance trends, 3498 Escherichia coli UTI isolates were collected from 2010 to 2014 in the …
resistance trends, 3498 Escherichia coli UTI isolates were collected from 2010 to 2014 in the …
High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal
Abstract Background Urinary Tract Infection (UTI) is one of the most common infectious
diseases and people of all age-groups and geographical locations are affected. The impact …
diseases and people of all age-groups and geographical locations are affected. The impact …
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
PNA Harris, JK Ferguson - International journal of antimicrobial agents, 2012 - Elsevier
Some bacteria that possess chromosomally determined AmpC β-lactamases may express
these enzymes at a high level following exposure to β-lactams, either by induction or …
these enzymes at a high level following exposure to β-lactams, either by induction or …
Fosfomycin: a first‐line oral therapy for acute uncomplicated cystitis
GG Zhanel, AJ Walkty… - Canadian Journal of …, 2016 - Wiley Online Library
Fosfomycin is a new agent to Canada approved for the treatment of acute uncomplicated
cystitis (AUC) in adult women infected with susceptible isolates of E. coli and Enterococcus …
cystitis (AUC) in adult women infected with susceptible isolates of E. coli and Enterococcus …
[HTML][HTML] Healthcare-associated urinary tract infections in urology
J Medina-Polo, KG Naber… - GMS infectious diseases, 2021 - ncbi.nlm.nih.gov
The purpose of the present review is to report the incidence and characteristics of healthcare-
associated urinary tract infections (HAUTIs) in urology with their microbiological and …
associated urinary tract infections (HAUTIs) in urology with their microbiological and …
[HTML][HTML] Guidelines for antibiotic prescription in intensive care unit
GC Khilnani, K Zirpe, V Hadda, Y Mehta… - Indian journal of …, 2019 - ncbi.nlm.nih.gov
How to cite this article: Khilnani GC, Zirpe K, Hadda V, Mehta Y, Madan K, Kulkarni A,
Mohan A, Dixit S, Guleria R, Bhattacharya P. Guidelines for Antibiotic Prescription in …
Mohan A, Dixit S, Guleria R, Bhattacharya P. Guidelines for Antibiotic Prescription in …